Algernon Pharmaceuticals Inc (AGNPF)

[markna]

So frustrating . . . these changes in timelines are very long. Also knowing that biotech's rarely complete according to timelines given ahead of capital raise. These type of firms say what they feel is needed to raise the money. Big pharma won't be interested until there is human data, the company is using someone else's compound. I'd say would need to wait until end of 2022 or early 2023 for a pharma deal if phase 2 is positive. I've been concerned about this for a long time, sorry to all those waiting for this to turn around . . . will be interesting to see if they can now close the offering with this new information (longer times to data and more G&A to get there)